Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization

BACKGROUND: Heterogeneity of liver function and tumor burden in intermediate-stage hepatocellular carcinoma (HCC) results in different outcomes after transarterial chemoembolization (TACE). Easy albumin-bilirubin (EZ-ALBI), a simplified albumin-bilirubin (ALBI) score, has recently been proposed as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ananchuensook, Prooksa, Sriphoosanaphan, Supachaya, Suksawatamnauy, Sirinporn, Siripon, Nipaporn, Pinjaroen, Nutcha, Geratikornsupuk, Nopavut, Kerr, Stephen J., Thanapirom, Kessarin, Komolmit, Piyawat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199248/
https://www.ncbi.nlm.nih.gov/pubmed/35701739
http://dx.doi.org/10.1186/s12876-022-02366-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199248/
https://www.ncbi.nlm.nih.gov/pubmed/35701739
http://dx.doi.org/10.1186/s12876-022-02366-y

Ejemplares similares